Contribution of the Type II Chaperonin, TRiC/CCT, to Oncogenesis

Soung-Hun Roh1, Moses Kasembeli2, Deenadayalan Bakthavatsalam3

  • 1Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA. sroh@bcm.edu.

Insights

Molecular chaperones, including HSP70, HSP90, and the T-complex protein-1 ring complex (TRiC/CCT), are crucial for protein health and implicated in cancer development. Understanding TRiC’s role in cancer offers new therapeutic strategies.

Area of Science:

  • Molecular biology
  • Cellular biology
  • Oncology

Background:

  • Protein homeostasis, involving folding and maintenance, is vital for cell survival.
  • Molecular chaperones regulate protein folding, localization, and degradation.
  • Chaperone clients include key regulators of cell growth, suggesting a role in oncogenesis.

Purpose of the Study:

  • To review the role of chaperones, specifically HSP70 and HSP90, in cancer.
  • To highlight the emerging role of the chaperonin TRiC/CCT in cancer development and progression.
  • To explore how TRiC interacts with oncogenic clients to influence cancer cell biology.

Main Methods:

  • Literature review of existing studies on molecular chaperones and cancer.
  • Analysis of the known functions of HSP70, HSP90, and TRiC/CCT.
  • Examination of the interactions between TRiC and oncogenic proteins.

Main Results:

  • HSP70 and HSP90 are established players in various cancers.
  • TRiC/CCT is increasingly recognized for its involvement in cancer.
  • TRiC/CCT interacts with oncogenic clients, affecting growth deregulation, apoptosis, and genome instability.

Conclusions:

  • Chaperones, particularly TRiC/CCT, are significant in cancer pathogenesis.
  • Targeting TRiC's interaction with oncogenic clients presents a promising avenue for novel cancer therapies.
  • Further elucidation of TRiC's mechanisms in cancer is needed for therapeutic development.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

6.1K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K